Evidence-based interventional pain medicine according to clinical diagnoses. 16. Complex regional pain syndrome.
Complex regional pain syndrome (CRPS), formerly known as reflex sympathetic dystrophy is a pain syndrome with an unclear pathophysiology and unpredictable clinical course. The disease is often therapy resistant, the natural course not always favorable. The diagnosis of CRPS is based on signs and symptoms derived from medical history and physical examination. Pharmacological pain management and physical rehabilitation of limb function are the main pillars of therapy and should be started as early as possible. If, however, there is no improvement of limb function and persistent severe pain, interventional pain management techniques may be considered. Intravenous regional blocks with guanethidine did not prove superior to placebo but frequent side effects occurred.Therefore this technique receives a negative recommendation (2 A-). Sympathetic block is the interventional treatment of first choice and has a 2 B+ rating. Ganglion stellatum (stellate ganglion) block with repeated local anesthetic injections or by radiofrequency denervation after positive diagnostic block is documented in prospective and retrospective trials in patients suffering from upper limb CRPS. Lumbar sympathetic blocks can be performed with repeated local anesthetic injections. For a more prolonged lumbar sympathetic block radiofrequency treatment is preferred over phenol neurolysis because effects are comparable whereas the risk for side effects is lower (2 B+). For patients suffering from CRPS refractory to conventional treatment and sympathetic blocks, plexus brachialis block or continuous epidural infusion analgesia coupled with exercise therapy may be tried (2 C+). Spinal cord stimulation is recommended if other treatments fail to improve pain and dysfunction (2 B+). Alternatively peripheral nerve stimulation can be considered, preferentially in study conditions (2 C+).
van Eijs
Frank
F
Department of Anesthesiology and Pain Therapy, St. Elisabeth Hospital, Tilburg, The Netherlands.
Stanton-Hicks
Michael
M
Van Zundert
Jan
J
Faber
Catharina G
CG
Lubenow
Timothy R
TR
Mekhail
Nagy
N
van Kleef
Maarten
M
Huygen
Frank
F
D000700:Analgesics / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D017115:Catheter Ablation / Q000379:methods; D020918:Complex Regional Pain Syndromes / Q000175:diagnosis* / Q000628:therapy*; D003937:Diagnosis, Differential; D004599:Electric Stimulation Therapy / Q000379:methods; D019317:Evidence-Based Medicine; D006145:Guanethidine / Q000627:therapeutic use; D017408:Guidelines as Topic; D006801:Humans; D010147:Pain Measurement; D013565:Sympatholytics / Q000627:therapeutic use; D014664:Vasodilation / Q000187:drug effects
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D013565:Sympatholytics; D006145:Guanethidine